• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

China Kangtai Cactus Biotech to Present at the Rodman & Renshaw Annual Global Investment Conference in New York on September 11, 2009

Posted on: Wednesday, 9 September 2009, 08:00 CDT

HARBIN, China, Sept. 9 /PRNewswire-Asia-FirstCall/ -- China Kangtai Cactus Biotech Inc. (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based products in China, will present at the Rodman and Renshaw Annual Global Investment Conference to be held on September 9-11, 2009 in New York. China Kangtai Cactus Biotech will present as part of the Asia Track program on September 11, 2009 at 1:10 p.m. ET in the Kennedy I Salon on the 4th floor of the New York Palace Hotel.

A live webcast and slides of the presentation will be available at http://www.wsw.com/webcast/rrshq15/ckgt.ob . The webcast will be available for approximately three months. The PowerPoint presentation will be available at: http://www.hawkassociates.com .

CEO Jinjiang Wang will be available to meet in scheduled sessions with institutional investors at the conference on September 9-11 or in New York from September 14-15 and in Southern California from September 17-18. Institutional investors seeking to arrange a one on one meeting or teleconference with management outside of the conference while management is in the U.S. can contact Susan Zhou, 305-451-1888 or cactus@hawkassociates.com.

About China Kangtai Cactus Biotech, Inc.

China Kangtai Cactus Biotech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy drinks, beer, wine and liquor, extracts and powders, and animal feed. China Kangtai controls over 387 acres of plants and maintains an active R&D group that holds 18 product patents and is seeking another 12. China Kangtai's high-quality "green" products are sold throughout China via a distribution network that covers 12 of China's 23 provinces and two of China's four municipalities. More information may be found at http://www.biocactus.com or via e-mail: chinakangtai@gmail.com.

An online investor relations kit and investment profile on China Kangtai Cactus Biotech Inc. is available at http://www.hawkassociates.com/profile/ckgt.cfm . To subscribe to future releases via e-mail alert, visit http://www.hawkassociates.com/about/alert/ .

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements.

SOURCE China Kangtai Cactus Biotech Inc.

Source: PR Newswire

More News in this Category